Streetbeat News

Regulatory

HUBC

HUB Cyber Security has received a notification from Nasdaq regarding non-compliance with listing rules related to total assets and total revenue requirements.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:32 pm

CMND

Clearmind Medicine has announced the publication of a patent application under the PCT for a ketamine-based combination treatment. This development could enhance their intellectual property portfolio and potentially lead to new treatment options.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:28 pm

ASML

SMH

SOXL

SOXX

The Dutch government is expected to block ASML from providing repair and maintenance services to Chinese companies, impacting ASML's business and China's semiconductor production. This move aligns with US efforts to curb China's tech growth. ASML's stock was affected, and semiconductor ETFs may also be impacted.

Portfolio Pulse from Natan Ponieman

August 29, 2024 | 8:24 pm

GRAL

GRAIL has published detailed findings on the performance of its Galleri multi-cancer early detection test, specifically in detecting aggressive prostate cancers, in JCO Precision Oncology. The data supports the clinical performance of Galleri in identifying more aggressive forms of prostate cancer.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:24 pm

NARI

Inari Medical will present data from the PEERLESS trial at the TCT 2024 symposium. The trial compares the FlowTriever system to catheter-directed thrombolysis for treating intermediate-risk pulmonary embolism, providing crucial insights for clinicians.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:12 pm

ESTC

Elastic announced that a subset of the source code for Elasticsearch and Kibana will be licensed under the OSI-approved AGPL license. This move could impact the open-source community and the adoption of these products.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:05 pm

IPGP

IPG Photonics has sold its entire interest in its Russian subsidiary, IRE-Polus, for $51 million. This sale marks IPG's complete exit from Russia, following sanctions due to the Ukraine conflict.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:01 pm

NCNA

Trading for NCNA was halted at 4:00:11 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 8:00 pm

JNJ

Johnson & Johnson (NYSE:JNJ) has achieved a Golden Cross, a bullish technical pattern indicating potential upward momentum. The stock's 50-day SMA has crossed above the 200-day SMA, and it trades above key moving averages. Additionally, JNJ's FDA submission for nipocalimab and strategic acquisitions bolster its growth prospects.

Portfolio Pulse from Surbhi Jain

August 29, 2024 | 7:18 pm

HIMS

Former pharmacists have raised concerns about patient safety and compounding practices at Hims & Hers Health, as reported by Capitol Forum. This could impact the company's reputation and operations.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 7:09 pm